Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 64 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
CA5B
💬1. CA5B
| 2件: Nitrogen metabolism Nitrogen metabolism, Metabolic pathways | Acetazolamide
Acetazolamide
💬1. CA5B
| Acetazolamide | 8件: 13 13, 86, 90, 115, 154, 155, 225, 230 💬1. CA5B
| |||||||||||||||||||||||||||||||||||
| 2 |
CA5B
💬2. CA5B
| 2件: Nitrogen metabolism Nitrogen metabolism, Metabolic pathways | Dorzolamide
Dorzolamide
💬2. CA5B
| Dorzolamide | 1件: 90 90 💬2. CA5B
| |||||||||||||||||||||||||||||||||||
| 3 |
ADRA2A
💬3. ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Brimonidine
Brimonidine
💬3. ADRA2A
| Brimonidine | 2件: 13 13, 90 💬
| |||||||||||||||||||||||||||||||||||
| 4 |
ADRA2B
💬4. ADRA2B
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Brimonidine
Brimonidine
💬4. ADRA2B
| Brimonidine | 2件: 13 13, 90 💬
| |||||||||||||||||||||||||||||||||||
| 5 |
ADRA2C
💬5. ADRA2C
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Brimonidine
Brimonidine
💬5. ADRA2C
| Brimonidine | 2件: 13 13, 90 💬
| |||||||||||||||||||||||||||||||||||
| 6 |
DDC
💬6. DDC
| 9件: Tyrosine metabolism Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism 9件: Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Seroto ... | Carbidopa
Carbidopa
💬6. DDC
| Carbidopa | 7件: 6 6, 13, 17, 90, 140, 164, 201 💬
| |||||||||||||||||||||||||||||||||||
| 7 |
DRD1
💬7. DRD1
| 10件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Amphetamine addiction, Morphine addiction, Alcoholism 10件: Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap ... | Levodopa
Levodopa
💬7. DRD1
| Levodopa | 6件: 6 6, 17, 90, 140, 164, 201 💬
| |||||||||||||||||||||||||||||||||||
| 8 |
DRD2
💬8. DRD2
| 8件: Rap1 signaling pathway Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism 8件: Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap jun ... | Levodopa
Levodopa
💬8. DRD2
| Levodopa | 6件: 6 6, 17, 90, 140, 164, 201 💬
| |||||||||||||||||||||||||||||||||||
| 9 |
DRD3
💬9. DRD3
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Dopaminergic synapse | Levodopa
Levodopa
💬9. DRD3
| Levodopa | 6件: 6 6, 17, 90, 140, 164, 201 💬
| |||||||||||||||||||||||||||||||||||
| 10 |
DRD4
💬10. DRD4
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Dopaminergic synapse | Levodopa
Levodopa
💬10. DRD4
| Levodopa | 6件: 6 6, 17, 90, 140, 164, 201 💬
|